Master One Thing - Rapamycin Longevity Series

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging


Listen Later

Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.

Links

https://www.tornado-tx.com

Joan's LinkedIn

Joan’s research publications

Big thanks to TimePie for the research help for this episode

Rapamycin resources

Rapamycin.news

Rapamycin Facebook group

Rapamycin Reddit group

Connect with Krister on:

Twitter

LinkedIn

Instagram

Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

...more
View all episodesView all episodes
Download on the App Store

Master One Thing - Rapamycin Longevity SeriesBy Krister Kauppi

  • 4.6
  • 4.6
  • 4.6
  • 4.6
  • 4.6

4.6

11 ratings


More shows like Master One Thing - Rapamycin Longevity Series

View all
Huberman Lab by Scicomm Media

Huberman Lab

29,266 Listeners

Plain English with Derek Thompson by The Ringer

Plain English with Derek Thompson

2,278 Listeners

Modrn Wellness by Modrn Med

Modrn Wellness

15 Listeners

Zero to Well-Read by Book Riot

Zero to Well-Read

142 Listeners